Toxicity of cannabidiol and its metabolites in TM3 mouse Leydig cells: a comparison with primary human Leydig cells
Archives of Toxicology · 2024
DOI: 10.1007/s00204-024-03754-x ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Archives of Toxicology, 2024. Verfasst von Yuxi Li und 6 weiteren Autor:innen. Beteiligte Einrichtung: Division of Biochemical Toxicology, National Center for Toxicological Research, U.S. Food and Drug Administration, 3900 NCTR Road, Jefferson, AR, 720…. Hauptthemen laut MEDLINE: Cannabidiol, Leydig Cells, Cell Survival, Apoptosis. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: U.S. Food and Drug Administration.
Abstract (Originalsprache)
Cannabidiol (CBD), one of the major components extracted from the plant Cannabis sativa L. , has been used as a prescription drug to treat seizures in many countries. CBD-induced male reproductive toxicity has been reported in animal models; however, the underlying mechanisms remain unclear. We previously reported that CBD induced apoptosis in primary human Leydig cells, which constitute the primary steroidogenic cell population in the testicular interstitium. In this study, we investigated the effects of CBD and its metabolites on TM3 mouse Leydig cells. CBD, at concentrations below 30 µM, reduced cell viability, induced G1 cell cycle arrest, and inhibited DNA synthesis. CBD induced apoptosis after exposure to high concentrations (≥ 50 µM) for 24 h or a low concentration (20 µM) for 6 days. 7-Hydroxy-CBD and 7-carboxy-CBD, the main CBD metabolites of CBD, exhibited the similar toxic effects as CBD. In addition, we conducted a time-course mRNA-sequencing analysis in both primary human Leydig cells and TM3 mouse Leydig cells to understand and compare the mechanisms underlying CBD-induced cytotoxicity. mRNA-sequencing analysis of CBD-treated human and mouse Leydig cells over a 5-day time-course indicated similar responses in both cell types. Mitochondria and lysosome dysfunction, oxidative stress, and autophagy were the major enriched pathways in both cell types. Taken together, these findings demonstrate comparable toxic effects and underlying mechanisms in CBD-treated mouse and primary human Leydig cells.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Biochemical Toxicology, National Center for Toxicological Research, U.S. Food and Drug Administration, 3900 NCTR Road, Jefferson, AR, 72079, USA.
- Division of Genetic and Molecular Toxicology, National Center for Toxicological Research, U.S. Food and Drug Administration, 3900 NCTR Road, Jefferson, AR, 72079, USA.
- Office of the Commissioner, U.S. Food and Drug Administration, Silver Spring, MD, 20993, USA.
- Office of Food Additive Safety, Center for Food Safety and Applied Nutrition, U.S. Food and Drug Administration, College Park, MD, 20740, USA.
- Division of Biochemical Toxicology, National Center for Toxicological Research, U.S. Food and Drug Administration, 3900 NCTR Road, Jefferson, AR, 72079, USA. Si.Chen@fda.hhs.gov.
ORCID-Profile: Si Chen
Förderung
- U.S. Food and Drug Administration
Zitieren
APA
Li, Y., Wu, Q., Li, X., Cournoyer, P., Choudhuri, S., Guo, L., & Chen, S. (2024). Toxicity of cannabidiol and its metabolites in TM3 mouse Leydig cells: a comparison with primary human Leydig cells. Archives of Toxicology. https://doi.org/10.1007/s00204-024-03754-x
Vancouver
Li Y, Wu Q, Li X, Cournoyer P, Choudhuri S, Guo L, et al. Toxicity of cannabidiol and its metabolites in TM3 mouse Leydig cells: a comparison with primary human Leydig cells. Archives of Toxicology. 2024. doi:10.1007/s00204-024-03754-x
BibTeX
@article{Li2024,
author = {Li, Yuxi and Wu, Qiangen and Li, Xilin and Cournoyer, Patrick and Choudhuri, Supratim and Guo, Lei and Chen, Si},
title = {Toxicity of cannabidiol and its metabolites in TM3 mouse Leydig cells: a comparison with primary human Leydig cells},
journal = {Archives of Toxicology},
year = {2024},
doi = {10.1007/s00204-024-03754-x}
}
EUVIMED